You just read:

National Research Council of Canada and KalGene Pharmaceuticals announce license agreement for the development of novel Alzheimer's therapeutics

News provided by

Centre for Imaging Technology Commercialization (CIMTEC)

Jan 13, 2015, 15:40 ET